Eli Lilly's orforglipron is an investigational once-daily oral small molecule GLP-1 that does not carry restrictions on food and water intake, while retatrutide is a first-in-class once-weekly triple hormone receptor agonist activating GIP, GLP-1, and glucagon receptors [2]
Even though Semaglutide GLP-1 injections were primarily created to help patients manage their type 2 diabetes, many doctors will prescribe it as a form of weight loss medication
The figures published by altRx are not derived from clinical trials or peer-reviewed studies and are representative of altRx patient experience only
As of March 5, 2026, this shortage would be declared resolved
Monitor your thyroid hormone levels regularly: GLP-1 medications dont treat thyroid function, so youll still need to monitor your TSH, T3, and T4 levels